Fiche publication
Date publication
mars 2005
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRONOWICKI Jean-Pierre
Tous les auteurs :
Bronowicki JP, Barraud H, Peyrin-Biroulet L
Lien Pubmed
Résumé
The estimated prevalence of hepatitis C infection in France is of 0.86%. The use of intravenous drugs is currently the main cause of hepatitis C infection and it may be responsible for 4400 new infections per year in France. The acute HCV infection is commonly asymptomatic and the progression from acute to chronic hepatitis range from 55 to 85%. Age at infection, alcohol consumption and gender have a significant impact on the progression of fibrosis. The fibrosis seems to progress linearly with an acceleration after 50 years of age. HCV is the second cause of cirrhosis and hepatocellular carcinoma in France.
Référence
Rev Prat. 2005 Mar 31;55(6):607-14.
